A comprehensive view of Blood Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer acquires Global Blood Therapeutics for US$5.4B, with deal closing expected in Q4 2022; deal includes Global Blood Therapeutics’ oral sickle cell drug Oxbryta, which had Q1 sales of US$55M
Published: August 09, 2022 by FiercePharma
Late-stage biotechnology firm Orca Bio starts Phase 3 study of its cell therapy Orca-T in patients with acute myeloid leukemia, acute lymphocytic leukemia, high-risk myelodysplastic syndromes; study to enroll 174 patients at 20 transplant centers in US
Published: August 08, 2022 by Business Wire
Roche partners with clinical-stage biopharmaceutical firm Poseida for exclusive rights, options to develop, commercialize Poseida’s allogeneic CAR-T programs directed at hematologic malignancies; Poseida receives US$110M upfront as part of deal
Published: August 04, 2022 by PR Newswire
Bristol Myers names Oswaldo Bernal Carmona as general manager of its Mexican subsidiary, replacing Sandra Ramirez who left the job in May; Bernal had been serving as the leader of Bristol Myers' Hematology and Innovative Medicines unit in Mexico
Published: August 03, 2022 by CE Noticias Financieras
Novo Nordisk reports late-stage study shows injectable prophylactic concizumab reduced spontaneous, traumatic bleeds in hemophilia patients by 86%; company to seek US, Japanese approval of drug later this year
Published: July 12, 2022 by SeeNews Pharmaceuticals

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count